Event Date/Time: May 20, 2013 / 8:45 am - (PST) End Date/Time: May 21, 2013 / 5:00 pm - (PST)
Report as Spam


Life Science Accounting Update Conference

From health care reform implications to collaboration accounting to valuing R&D, this conference will address the latest developments in key areas. You'll hear from experts at Deloitte, Ernst & Young, PwC, KPMG, life science analysts and your industry counterparts.

Learning Objectives:
  • Understand the latest accounting changes in key areas
  • Recognize the timelines and key factors affecting the life science industry
  • Begin to assess the effects of these standards on your company or clients
Registration Information:

Cost $995 Discounts are shown at checkout and still available: Save $200 if you register by April 12th Register any one of three ways: 1. Register online using a credit card and click the orange button 2. Register by phone at (610) 789-3110 3. Email your contact info to be invoiced to We have a block of discounted rooms available and will email you the link after you register. The hotel is located 6.5 miles from the airport.

Agenda: DAY 1 8:00 8:45 Continental Breakfast and Registration 8:45 9:30 Roundtable discussion 9:30 9:40 Break 9:40 11:20 Technical Accounting Update Update on latest relevant developments, amendments and EITFs What Is the SEC staff looking for? Meaningful MD&A Loss contingency disclosures Segment reporting Non-GAAP 11:20 11:30 Break 11:30 12:15 Impact of Social Media Social media within the current regulatory landscape Direct to consumer promotional activities How to actively manage risk 12:15 1:15 Lunch 1:15 2:45 Industry Panel: Accounting Issues Introduction and thumbnail profile from panelists Best practices in applying the onslaught of accounting changes Obstacles and opportunities What's on the horizon? 2:45 2:55 Break 2:55 4:25 Revenue Recognition Accounting Status of joint project Summary of key provisions Implementation considerations 4:25 4:35 Break 4:35 5:35 Tax Issues for Life Science Companies International Tax Reform discussion overview (the "CAMP" discussion) Obama budget tax proposals U.S. Job Creation and International Tax Reform Act of 2012 Repatriation holiday Agenda: DAY 2 8:30 10:00 Collaboration Accounting Multiple Element Arrangements and Revenue Recognition Accounting evaluation steps SEC comments and trends Milestone method disclosures 10:00 10:15 Break 10:15 11:00 Leasing Overview and timing Lessee accounting How will the income statement look? How are companies preparing for the change? 11:00 12:00 Legal Update Recent Division of Corporation Finance Guidance Dodd Frank Recent SEC Comment Letter Themes 12:00 1:00 Lunch 1:00 2:15 Valuation Issues Fair value accounting Industry standards for valuation models Valuing R&D Projects Valuation and impairment of intangible assets 2:15 2:30 Break 2:30 3:15 Industry Overview Macroeconomic picture Key trends driving M&A landscape IPO Market 3:15 4:15 Fraud Issues in the Life Science Industry Fraud trends Recent cases Anti-fraud programs Foreign Corrupt Practices Act Conference speakers include:

Brian Jobe, Deloitte, Partner in Deloitte & Touche LLP's Financial Accounting and Reporting Services practice, and currently leads the practice's efforts related to the Life Sciences industry. For the past eleven years, Brian has provided accounting policy, transaction structuring, technology, and other consulting services to Fortune 1000 and international companies. Chip Baird, PTC Therapeutics Nicole Brookshire, Cooley, Partner with focus on corporate and securities law, with a particular emphasis on representation of public companies. Prasadh Cadambi, Financial Accounting Standards Board, Practice Fellow Andreas Chrysostomou, Duff & Phelps, Managing Director and Global Leader of the Integrated Healthcare group with focus on Life Science Industry John Crowley, Vertex Pharmaceuticals, Senior Director of Accounting Mark Drozdowski, KPMG, Partner and National Audit Leader for Life Science Industry Bill Knerr, Ernst & Young, Manager of Life Science Group Bill is a senior Manager in Ernst & Young's assurance practice. Bill is currently serving a three year rotation as the Life Sciences Sector Resident in Ernst & Young's National Professional Practice Group. In this position, Bill consults with E&Y professionals and Life Sciences clients on accounting, auditing and reporting issues, including complex and innovative transactions. Bill is also responsible for developing thought leadership publications on recent standard setting activity and emerging accounting and financial reporting issues for Life Sciences companies. Prior to moving to New York, Bill served Pharmaceutical and Biotechnology clients in Indianapolis, including Eli Lilly. Winston Kung, Citigroup, Managing Director with emphasis on pharma and banking Anthony Torrington, Ernst & Young, Partner and leader in Life Science Practice Tony is partner in the Assurance practice, with 20 years of experience serving principally high growth life science clients at various stages of development. His technical background focuses on SEC accounting and reporting matters, including filings of registration statements, quarterly and annual reporting on Form 10-Q and Form 10-K, private offering memorandums, acquisition and disposition accounting, revenue recognition matters including, and equity related accounting issues. Tony's current public client responsibilities include Covance, Immunomedics, Delcath Systems, and Aegerion Pharmaceuticals. Tony also served on numerous other public and private companies in the life sciences sector. These companies included Medarex (sold to BMS), Amicus, Genentech, Nekktar, Barrier Therapeutics, Eyetech Pharmaceuticals, Qualitest Pharmaceuticals (sold to Endo), Cardinal Health - Pharmaceuticals and Technologies (now Catalent), Avigen Pharmaceuticals, Axys Pharmaceuticals, ESP Pharma, Esprit Pharma, Sangamo Biosciences, InterMune Pharmaceuticals, MIM Corporation, Titan Pharmaceuticals, and many others. Andre Van Hoek, Celgene, Corporate VP, Controller and Chief Accounting Officer PwC Tax Group - Names TBA


5101 Great America Pkwy
Santa Clara
United States